China Resources Pharmaceutical Group Ltd (3320) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
59
About the Report
About the Report
Summary
China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise chemical medicines, TCMs, biologics, and health food and traditional Chinese medicine, and nutritional products. CR Pharma offers products in forms of oral solid dosage, large infusion bags, powder vials, oral liquid dosage, injections, and topical preparations. The company markets its products through logistics, wholesale, retail and supply chain services in different provinces across China. CR Pharma is headquartered in Hong Kong.
China Resources Pharmaceutical Group Ltd (3320)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
China Resources Pharmaceutical Group Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deal Details 15
Partnerships 15
China Resources Pharmaceutical Enters into Agreement with Fujifilm 15
China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 16
Pfizer and CR Saike Pharma Enter into Distribution Agreement 17
China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 18
China Resources Zizhu Enters into Agreement with Uni-Bio Science 19
China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 20
China Resources Sanjiu Medical To Form Joint Venture 21
Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 22
Licensing Agreements 23
China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 23
China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 24
Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 25
Equity Offering 26
China Resources Pharma Raises USD1.8 Million in IPO 26
Debt Offering 28
China Resources Double Crane Pharma to Raise USD217.8 Million in Public Offering of Bonds 28
Acquisition 29
China Resources Double-Crane Pharma Acquires Hainan Zhonghua Union Pharma 29
China Resources Pharma Acquires 20% Stake in Hefei Tianmai Biotechnology 30
China Resources Sanjiu Medical Acquires Kunming Shenghuo Pharmaceutical 31
China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 32
China Resources Double-Crane Pharma to Acquire 60% Stake in Jinan-based Pharmaceutical Company 33
China Resources Double Crane Pharma Acquires China Resources Saike Pharma for USD578.6 Million 34
The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lan's Int'l Medicine Investment 35
China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For USD 94 Million 36
Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For USD 245 Million 37
Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For USD 2 Million 38
China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For USD 95 Million 39
China Resources Pharmaceutical Group Ltd-Key Competitors 40
China Resources Pharmaceutical Group Ltd-Key Employees 41
China Resources Pharmaceutical Group Ltd-Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 44
Financial Announcements 44
Mar 21, 2018: China Resources Pharmaceutical Group: Annual Results Announcement For The Year Ended 31 December 2017 44
Aug 24, 2017: China Resources Pharmaceutical Group: Interim Results Announcement For The Six Months Ended 30 June 2017 53
Corporate Communications 57
May 21, 2018: China Resources Pharmaceutical: Change Of Non-Executive Directors And Member Of The Audit Committee 57
Aug 07, 2017: China Resources Pharmaceutical: Appointment of Independent Non-executive Director 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
List of Figure
List of Figures
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11
List of Table
List of Tables
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
China Resources Pharmaceutical Enters into Agreement with Fujifilm 15
China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 16
Pfizer and CR Saike Pharma Enter into Distribution Agreement 17
China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 18
China Resources Zizhu Enters into Agreement with Uni-Bio Science 19
China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 20
China Resources Sanjiu Medical To Form Joint Venture 21
Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 22
China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 23
China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 24
Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 25
China Resources Pharma Raises USD1.8 Million in IPO 26
China Resources Double Crane Pharma to Raise USD217.8 Million in Public Offering of Bonds 28
China Resources Double-Crane Pharma Acquires Hainan Zhonghua Union Pharma 29
China Resources Pharma Acquires 20% Stake in Hefei Tianmai Biotechnology 30
China Resources Sanjiu Medical Acquires Kunming Shenghuo Pharmaceutical 31
China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 32
China Resources Double-Crane Pharma to Acquire 60% Stake in Jinan-based Pharmaceutical Company 33
China Resources Double Crane Pharma Acquires China Resources Saike Pharma for USD578.6 Million 34
The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lan's Int'l Medicine Investment 35
China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For USD 94 Million 36
Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For USD 245 Million 37
Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For USD 2 Million 38
China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For USD 95 Million 39
China Resources Pharmaceutical Group Ltd, Key Competitors 40
China Resources Pharmaceutical Group Ltd, Key Employees 41
China Resources Pharmaceutical Group Ltd, Other Locations 42
China Resources Pharmaceutical Group Ltd, Subsidiaries 42
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.